Cough Syrup: 18 Children died suspiciously in Uzbekistan after drinking cough syrup manufactured by an Indian company. The Government of Uzbekistan informed about this to the Government of India, after which the company was raided.
Noida: Three people have been arrested by the police in connection with the death of 18 children in Uzbekistan allegedly after drinking cough syrup made in India. In fact, on the complaint of the drug inspector of Ghaziabad, after the samples of the medicine taken were not found to be up to the standards, a case was registered in Police Station Phase-3 last night, after which the police took this action.
Police have arrested three people including the operation head in this case while the owner of the company is absconding and search is on for him.
Cough syrup did not meet the standards
The Police Commissioner’s Office said that Ghaziabad’s Drug Inspector Ashish has filed a report in Police Station Phase-3 last night. He has alleged that the cough syrup manufactured in a pharmaceutical company located in Sector 67 did not meet the standards.
The office said that in this case, against the company’s director Jaya Jain, Sachin Jain, operation head Tuhin Bhattacharya, manufacturing chemist Atul Rawal and Mool Singh, etc. under sections 274, 275, 276, Drugs and Cosmetics Act 17,17A,17-B. Case has been registered under.
According to an official associated with the office, the police have arrested Tuhin Bhattacharya, Atul Rawat and Mool Singh. He told that the owner of the company, the mistress, is absconding, whose search is on. He claimed that he would be arrested soon.
Suspicious death of 18 children in December 2022
In the month of December 2022, 18 children died suspiciously in Uzbekistan after drinking syrup made by the said company. On the basis of the information of the Government of Uzbekistan, the Government of India took this matter seriously and raids were conducted on the company.
Company’s drug license has been already suspended
The Uttar Pradesh Food Safety and Drug Administration (FSDA) department had suspended the drug manufacturing license of Sector-67-based pharmaceutical firm Marian Biotech Pvt Ltd following the alleged death of 19 children in Uzbekistan. Apart from drug record maintenance, the company’s drug production license has been suspended for not providing timely information on raw material purchase.
A team from central agencies and the Uttar Pradesh Department of Pharmaceuticals had inspected the company’s office here on December 29 last year and taken six more samples for testing. Gautam Budh Nagar’s Drug Inspector Vaibhav Babbar had told that during the inspection the company’s representative could not present the documents related to the production of ‘Doc-1 Max’, after which the government had immediately banned its production.
